Walvax Biotechnology Co., Ltd. (SHE:300142)
China
· Delayed Price · Currency is CNY 11.71
+0.04 (0.34%)
At close: Dec 5, 2025
Walvax Biotechnology Revenue
Walvax Biotechnology had revenue of 564.60M CNY in the quarter ending September 30, 2025, a decrease of -20.25%. This brings the company's revenue in the last twelve months to 2.40B, down -22.54% year-over-year. In the year 2024, Walvax Biotechnology had annual revenue of 2.82B, down -31.41%.
Revenue (ttm)
2.40B
Revenue Growth
-22.54%
P/S Ratio
7.81
Revenue / Employee
1.00M
Employees
2,388
Market Cap
18.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.82B | -1.29B | -31.41% |
| Dec 31, 2023 | 4.11B | -972.67M | -19.12% |
| Jan 1, 2023 | 5.09B | 1.62B | 46.89% |
| Jan 1, 2022 | 3.46B | 523.81M | 17.82% |
| Dec 31, 2020 | 2.94B | 1.82B | 162.13% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| WuXi AppTec | 43.88B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Sichuan Biokin Pharmaceutical | 2.23B |
| Shanghai United Imaging Healthcare | 12.20B |
| Aier Eye Hospital Group | 22.17B |
| Zhangzhou Pientzehuang Pharmaceutical., | 9.78B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |